JP2020503341A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020503341A5 JP2020503341A5 JP2019536014A JP2019536014A JP2020503341A5 JP 2020503341 A5 JP2020503341 A5 JP 2020503341A5 JP 2019536014 A JP2019536014 A JP 2019536014A JP 2019536014 A JP2019536014 A JP 2019536014A JP 2020503341 A5 JP2020503341 A5 JP 2020503341A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- groups
- disease
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611260514.6 | 2016-12-30 | ||
| CN201611260514.6A CN108264535A (zh) | 2016-12-30 | 2016-12-30 | 一种抗抑郁化合物及其制备方法和应用 |
| PCT/CN2017/120134 WO2018121770A1 (zh) | 2016-12-30 | 2017-12-29 | 一种抗抑郁化合物及其制备方法和应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020503341A JP2020503341A (ja) | 2020-01-30 |
| JP2020503341A5 true JP2020503341A5 (enExample) | 2021-05-27 |
| JP6901569B2 JP6901569B2 (ja) | 2021-07-14 |
Family
ID=62707894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536014A Active JP6901569B2 (ja) | 2016-12-30 | 2017-12-29 | 抗うつ化合物およびその製造方法と使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11142543B2 (enExample) |
| EP (1) | EP3564253B1 (enExample) |
| JP (1) | JP6901569B2 (enExample) |
| CN (2) | CN108264535A (enExample) |
| WO (1) | WO2018121770A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019129176A1 (zh) * | 2017-12-29 | 2019-07-04 | 中国科学院上海药物研究所 | 一种菝葜皂苷元衍生物及其制备方法和应用 |
| CN109988218B (zh) * | 2017-12-29 | 2022-11-25 | 中国科学院上海药物研究所 | 一种菝葜皂苷元衍生物及其制备方法和应用 |
| CN109206472A (zh) * | 2018-09-27 | 2019-01-15 | 华东理工大学 | 薯蓣皂苷元衍生物、其药物组合物及其应用 |
| CN109053854B (zh) * | 2018-09-29 | 2021-05-14 | 深圳清博汇能医药科技有限公司 | 基于知母菝契皂苷元结构的衍生物、药物组合物及其应用 |
| WO2020259612A1 (zh) * | 2019-06-26 | 2020-12-30 | 中国科学院上海药物研究所 | 一种抗抑郁甾体化合物 |
| CN113831382A (zh) * | 2020-06-24 | 2021-12-24 | 中国科学院上海药物研究所 | 一种甾体化合物 |
| CN113831381A (zh) * | 2020-06-24 | 2021-12-24 | 中国科学院上海药物研究所 | 一种用于治疗抑郁症的甾体化合物 |
| CN113292629B (zh) * | 2021-06-21 | 2022-04-26 | 西南民族大学 | 薯蓣皂苷元羟肟酸类衍生物及其制备方法和应用 |
| CN116621912A (zh) * | 2022-02-18 | 2023-08-22 | 北京清博汇能医药科技有限公司 | 基于菝契皂苷元结构的衍生物及其药物组合物的用途 |
| CA3252201A1 (en) * | 2022-02-18 | 2025-07-07 | Beijing Phytovent Pharmaceutical Tech Co Ltd | USE OF A SARSASAPOGENIN STRUCTURE-BASED DERIVATIVE AND ASSOCIATED PHARMACEUTICAL COMPOSITION |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| GB0000228D0 (en) | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
| NZ547344A (en) | 2002-03-27 | 2007-11-30 | Phytopharm Plc | Therapeutic methods and uses of sapogenins and their derivatives |
| WO2005051381A1 (en) * | 2003-11-26 | 2005-06-09 | Biovitrum Ab | Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) |
| WO2005051380A1 (en) * | 2003-11-26 | 2005-06-09 | Biovitrum Ab | Substituted urea-octahydroindols as antagonists of melanin concentrating hormone receptor 1 (mch1r) |
| US20050245495A1 (en) * | 2004-04-07 | 2005-11-03 | Chen Zhao | Azacyclosteroid histamine-3 receptor ligands |
| EP1781288A2 (en) * | 2004-08-19 | 2007-05-09 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CN101214253B (zh) | 2008-01-07 | 2011-09-21 | 中国人民解放军第二军医大学 | 知母皂苷b-ⅱ用于制备抗抑郁产品的用途 |
| KR20100119825A (ko) | 2008-03-05 | 2010-11-10 | 에프. 호프만-라 로슈 아게 | 2-아미노퀴놀린 |
| CN101768202B (zh) * | 2009-02-18 | 2013-10-30 | 沈阳药科大学 | 知母中菝葜皂苷元及其衍生物的制备方法及其医药新用途 |
| CN102924559B (zh) * | 2012-11-16 | 2015-10-28 | 沈阳药科大学 | 菝葜皂苷元衍生物及其制备和应用 |
| WO2015163318A1 (ja) * | 2014-04-25 | 2015-10-29 | レジリオ株式会社 | アルツハイマー病の治療剤を含む、神経細胞の軸索の機能不全が関与する疾患の治療剤 |
| WO2019129176A1 (zh) * | 2017-12-29 | 2019-07-04 | 中国科学院上海药物研究所 | 一种菝葜皂苷元衍生物及其制备方法和应用 |
-
2016
- 2016-12-30 CN CN201611260514.6A patent/CN108264535A/zh active Pending
-
2017
- 2017-12-29 CN CN201780081277.3A patent/CN110121502B/zh active Active
- 2017-12-29 JP JP2019536014A patent/JP6901569B2/ja active Active
- 2017-12-29 US US16/474,668 patent/US11142543B2/en active Active
- 2017-12-29 EP EP17889516.5A patent/EP3564253B1/en active Active
- 2017-12-29 WO PCT/CN2017/120134 patent/WO2018121770A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020503341A5 (enExample) | ||
| JP2020023528A5 (enExample) | ||
| JP2020510091A5 (enExample) | ||
| JP2018070614A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2017511360A5 (enExample) | ||
| JP2018504437A5 (enExample) | ||
| JP2016512531A5 (enExample) | ||
| JP2006506466A5 (enExample) | ||
| JP2016040288A5 (enExample) | ||
| JP2007529421A5 (enExample) | ||
| JP2018503663A5 (enExample) | ||
| JP2009526034A5 (enExample) | ||
| JP2013541503A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2020529994A5 (enExample) | ||
| JP2019515908A5 (enExample) | ||
| RU2011133128A (ru) | Противоопухолевые соединения дигидропиран-2-она | |
| JP2019522055A5 (enExample) | ||
| JPWO2022222921A5 (enExample) | ||
| RU2009142430A (ru) | Производные триазолопиридинкарбоксамидов, их получение и применение в терапии | |
| JP2007507494A5 (enExample) | ||
| JP2019520344A5 (enExample) | ||
| JP2014506582A5 (enExample) | ||
| JP2019526546A5 (enExample) |